MET
72
5
WFC
79
4
AON
54
2
JWN
48
6
INTU
56
-4
PRGO
39
3
NWL
53
3
VMC
57
4
AA
48
-12
RSG
71
3
MSFT
50
3
CL
58
2
MAS
58
2
HAS
33
3
LNC
39
3
MCD
52
2
GT
62
6
NRG
49
-3
CMA
61
5
SLB
55
2
MET
72
5
WFC
79
4
AON
54
2
JWN
48
6
INTU
56
-4
PRGO
39
3
NWL
53
3
VMC
57
4
AA
48
-12
RSG
71
3
MSFT
50
3
CL
58
2
MAS
58
2
HAS
33
3
LNC
39
3
MCD
52
2
GT
62
6
NRG
49
-3
CMA
61
5
SLB
55
2
Financhill
Back

BridgeBio Pharma Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
57

BBIO
BridgeBio Pharma

Last Price:
23.44
Seasonality Move:
10.74%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
244.97
Seasonality Move:
11.66%
Buy
57
BridgeBio Pharma (BBIO) is a Buy

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $23.42. The Score for BBIO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $244.89. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $23.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $244.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.57 Sell
Relative Strength Index (14 RSI): 43.16 Sell
Chaikin Money Flow: 1274301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.33 - 25.59) Sell
Bollinger Bands (100): (24 - 27.4) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.65 Sell
Relative Strength Index (14 RSI): 37.82 Sell
Chaikin Money Flow: -229766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (250.02 - 288.16) Sell
Bollinger Bands (100): (248.72 - 281.72) Sell

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.4 Buy
20-day SMA: 24.44 Sell
50-day SMA: 24.96 Sell
200-day SMA: 27.29 Sell
8-day EMA: 23.54 Sell
20-day EMA: 24.2 Sell
50-day EMA: 24.92 Sell
200-day EMA: 26.48 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 245.62 Sell
20-day SMA: 263.27 Sell
50-day SMA: 272.49 Sell
200-day SMA: 211.63 Buy
8-day EMA: 248.36 Sell
20-day EMA: 259.36 Sell
50-day EMA: 265.3 Sell
200-day EMA: 231.03 Buy

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.35 per share, and a decrease next year of $2.41 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):